The goal of this work was to systematically characterize and detect class 1, 2, and 3 integrons with many antibiotic resistance A. baumannii strains collected from a clinical environment in Iraq’s Al-Muthanna hospitals. In this investigation, 24 non-replicated clinical strains of A. baumannii were evaluated using Chrome agar as a selective medium and PCR of the rplB gene. The clonal relatedness of the isolates to class 1 integron was evaluated using a PCR technique. The prevalence of class 1 integron was detected by PCR in only 12 clones of A. baumannii followed by HinfI digestion analysis showing three identical bands at 160 bp, 1350 bp, and 870 bp. In addition, PCR sequencing confirmed the presence of gene cassette arrays consisting of aacA4-catB8-aadA1 (100%) in class 1 integron. The sequence analysis of the integron shows 97.87 identity with A. baumannii isolates from Australia (GenBank accession number CP054302) among A. baumannii isolates. The blast analysis of this class I integron showed that the presence of the intI1, aacA4-catB8-aadA1 genes can considerably boost the acquisition of MDR phenotypes in A. baumannii isolates. We concluded that antibiotics of many types are widely used. The presence of integrons in A. baumannii is concerning for public health. In the clinical setting, it appears that the class 1 integron can be used as a predictive biomarker for the presence of MDR phenotypes. In these bacteria, however, the integron does not possess carbapenemases genes.
This is a preview of subscription content, access via your institution
Subscribe to Journal
Get full journal access for 1 year
only $9.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
All data from this study are accessible upon request from the corresponding author.
Gholami M, Haghshenas M, Moshiri M, Razavi S, Pournajaf A, Irajian G, Heidary M. Frequency of 16S rRNA methylase and aminoglycoside-modifying enzyme genes among clinical isolates of Acinetobacter baumannii in Iran. Iran J Pathol. 2017;12:329–38
Elshamy AA, Aboshanab KMJFsO. A review on bacterial resistance to carbapenems: epidemiology, detection and treatment options. Future Sci OA. 2020;6:FSO438 https://doi.org/10.2144/fsoa-2019-0098
Mirshekar M, Shahcheraghi F, Azizi O, Solgi H, Badmasti FJMDR. Diversity of class 1 integrons, and disruption of carO and dacD by insertion sequences among Acinetobacter baumannii isolates in Tehran, Iran. Microb Drug Resist. 2018;24:359–66. https://doi.org/10.1089/mdr.2017.0152
Koczura R, Przyszlakowska B, Mokracka J, Kaznowski AJCm. Class 1 Integrons and Antibiotic Resistance of Clinical Acinetobacter calcoaceticus–baumannii Complex in Poznań, Poland. Curr Microbiol. 2014;69:258–62. https://doi.org/10.1007/s00284-014-0581-0
Qin J, Maixnerová M, Nemec M, Feng Y, Zhang X, Nemec A, Zong Z. Acinetobacter cumulans sp. nov., isolated from hospital sewage and capable of acquisition of multiple antibiotic resistance genes. Syst Appl Microbiol Biotechnol. 2019;42:319–25. https://doi.org/10.1016/j.syapm.2019.02.001
Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol. 2007;5:939–51.https://doi.org/10.1038/nrmicro1789
Adewoyin MA, Okoh AI. The natural environment as a reservoir of pathogenic and non-pathogenic Acinetobacter species. Rev Environ Health. 2018;33:265–72. https://doi.org/10.1515/reveh-2017-0034
Harding CM, Hennon SW, Feldman MFJNRM. Uncovering the mechanisms of Acinetobacter baumannii virulence. Nat Rev Microbiol. 2018;16:91–102. https://doi.org/10.1038/nrmicro.2017.148
Higgins PG, Hagen RM, Kreikemeyer B, Warnke P, Podbielski A, Frickmann H, Loderstädt U. Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii isolates from Northern Africa and the Middle East. Antibiotics. 2021;10:291 https://doi.org/10.3390/antibiotics10030291
Gootz TD, Marra A. Acinetobacter baumannii: an emerging multidrug-resistant threat. Expert Rev Anti-infective Ther. 2008;6:309–25. https://doi.org/10.1586/1478722.214.171.1249
De Francesco MA, Ravizzola G, Peroni L, Bonfanti C, Manca N. Prevalence of multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa in an Italian hospital. Infect Public Health. 2013;6:179–85. https://doi.org/10.1016/j.jiph.2012.11.006
Goudarzi M, Azimi HJJJoM. Dissemination of classes 1, 2, and 3 integrons in acinetobacter baumannii strains recovered from intensive care units using polymerase chain reaction-restriction fragment length polymorphism. Jundishapur J Microbiol. 2017;10. https://doi.org/10.5812/jjm.13100
MacFaddin JJP. Biochemical tests for identification of medical bacteria. 3th ed. Philadelphia: Lippincott Williams & Wilkins; 2000. p. p.113. PA
Abhari SS, Azizi O, Modiri L, Aslani MM, Assmar M, Fereshteh S, Badmasti F. Two new rapid PCR-based methods for identification of Acinetobacter baumannii isolated from clinical samples. Mol Cell Probes. 2021;58:101732 https://doi.org/10.1016/j.mcp.2021.101732
Weinstein MP, Lewis JS. The clinical and laboratory standards institute subcommittee on antimicrobial susceptibility testing: background, organization, functions, and processes. J Clin Microbiol. 2020;58:e01864–19. JJocm
Kristo I, Pitiriga V, Poulou A, Zarkotou O, Kimouli M, Pournaras S, Tsakris A. Susceptibility patterns to extended-spectrum cephalosporins among Enterobacteriaceae harbouring extended-spectrum β-lactamases using the updated Clinical and Laboratory Standards Institute interpretive criteria. Int J Antimicrobial Agents. 2013;41:383–7. https://doi.org/10.1016/j.ijantimicag.2012.12.003
Azizi O, Fereshteh S, Nasiri O, Ghorbani M, Barzi SM, Badmasti FJJJoM. The occurrence and characterization of class I, II, and III integrons among carbapenemase-producing clinical strains of Acinetobacter baumannii in tehran, iran. Jundishapur J Microbiol. 2021;14:1–13. https://doi.org/10.5812/jjm.117766
Case RJ, Boucher Y, Dahllöf I, Holmström C, Doolittle WF, Kjelleberg S. Use of 16S rRNA and rpoB genes as molecular markers for microbial ecology studies. Appl Environ Microbiol. 2007;73:278–88. https://doi.org/10.1128/AEM.01177-06
El-Shazly S, Dashti A, Vali L, Bolaris M, Ibrahim AS. Molecular epidemiology and characterization of multiple drug-resistant (MDR) clinical isolates of Acinetobacter baumannii. Int J Infect Dis. 2015;41:42–9. https://doi.org/10.1016/j.ijid.2015.10.016
Roberts LW, Forde BM, Hurst T, Ling W, Nimmo GR, Bergh H, George N, Hajkowicz K, McNamara JF, Lipman J, Permana B, Schembri MA, Paterson D, Beatson SA, Harris PNA. Genomic surveillance, characterisation and intervention of a carbapenem-resistant Acinetobacter baumannii outbreak in critical care. medRxiv. 2020. https://doi.org/10.1101/2020.08.10.20166652
Turton JF, Kaufmann ME, Glover J, Coelho JM, Warner M, Pike R, Pitt TL. Detection and typing of integrons in epidemic strains of Acinetobacter baumannii found in the United Kingdom. J Clin Microbiol. 2005;43:3074–82. https://doi.org/10.1128/JCM.43.7.3074-3082.2005
Zhu Y, Yi Y, Liu F, Lv N, Yang X, Li J, Hu Y, Zhu B. Distribution and molecular profiling of class 1 integrons in MDR Acinetobacter baumannii isolates and whole genome-based analysis of antibiotic resistance mechanisms in a representative strain. Microbiol Res. 2014;169:811–6. https://doi.org/10.1016/j.micres.2014.04.002
Chen X, Li GX, Zhang H, Yuan M, Hou XP, Yu HL, Li J. Characterization of class 1 integron gene cassettes among clinical bacteria isolated from one large hospital in northern China. Biomed Environ Sci. 2013;26:1003–7. https://doi.org/10.3967/bes2013.038
Khorsi K, Messai Y, Hamidi M, Ammari H, Bakour R. High prevalence of multidrug-resistance in Acinetobacter baumannii and dissemination of carbapenemase-encoding genes blaOXA-23-like, blaOXA-24-like and blaNDM-1 in Algiers hospitals. Asian Pac J tropical Med. 2015;8:438–46. https://doi.org/10.1016/j.apjtm.2015.05.011
Hall RM. Integrons and gene cassettes: hotspots of diversity in bacterial genomes. Ann N Y Acad Sci. 2012;1267:71–8. https://doi.org/10.1111/j.1749-6632.2012.06588.x
Gillings M, Boucher Y, Labbate M, Holmes A, Krishnan S, Holley M, Stokes HW. The evolution of class 1 integrons and the rise of antibiotic resistance. J Bacteriol. 2008;190:5095–100. https://doi.org/10.1128/JB.00152-08
Norrby SR. Integrons: adding another threat to the use of antibiotic therapy. Clin Infect Dis. 2005;41:10–1. https://doi.org/10.1086/430715
Poonsuk K, Tribuddharat C, Chuanchuen R. Class 1 integrons in Pseudomonas aeruginosa and Acinetobacter baumannii isolated from clinical isolates. Southeast Asian J Tropical Med Public Health. 2012;43:376–84. JSAJoTM, Health PPMID: 23082590
Zhong Q, Xu W, Wu Y, Xu H. Clonal spread of carbapenem non-susceptible Acinetobacter baumannii in an intensive care unit in a teaching hospital in China. Ann Lab Med. 2012;32:413–9. https://doi.org/10.3343/alm.2012.32.6.413
Chen J, Li H, Yang J, Zhan R, Chen A, Yan Y. Prevalence and characterization of integrons in multidrug resistant Acinetobacter baumannii in Eastern China: a multiple-hospital study. Int J Environ Res. 2015;12:10093–105. https://doi.org/10.3390/ijerph120810093
I would like to express our heartfelt thanks to our staff in the microbiology lab at the al Muthanna University for providing facility to do the whole experiments.
Conflict of interest
The author declares no competing interests.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Alabdali, Y.A.J. Antibiotic resistance and carriage class I integron in clinical isolates of Acinetobacter baumannii from Al Muthanna, Iraq. J Antibiot 75, 691–697 (2022). https://doi.org/10.1038/s41429-022-00569-9